One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry

Bruno Versaevel

Post-Print from HAL

Date: 2018-03-15
Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-01960426v1
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published in "L'Atelier du médicament" de la chaire Hospinnomics de PSE (Paris School of Economics) et de l'APHP (Assistance Publique Hopitaux de Paris), Mar 2018, Paris, France

Downloads: (external link)
https://shs.hal.science/halshs-01960426v1/document (application/pdf)

Related works:
Journal Article: One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry (2019)
Working Paper: One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry (2019)
Working Paper: One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry (2018)
Working Paper: One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry (2017)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-01960426

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().